| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |